Xefta 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Xefta 250 mg Tablet

Xefta 250 mg Tablet

Xefta 250 mg Tablet contains gefitinib 250 mg, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It is an oral prescription tablet taken according to the oncologist’s treatment plan. Gefitinib works by blocking EGFR signaling involved in the growth of cancer cells.

BUY NOW

Category

Xefta 250 mg Tablet is used for adults with non-small cell lung cancer, particularly tumors with specific EGFR abnormalities. Gefitinib belongs to the tyrosine kinase inhibitor class and selectively inhibits epidermal growth factor receptor signaling. The treatment dose and duration are determined by the treating oncologist based on the patient’s cancer characteristics and clinical response. Xefta 250 mg is marketed by Dr. Reddy’s Laboratories Ltd. and is listed in a 10-tablet pack in India.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Xefta 250 mg Tablet, Xefta 250 Tablet, Xefta Gefitinib 250 mg, Gefitinib 250 mg Tablet, Gefitinib Lung Cancer Tablet, Gefitinib EGFR Inhibitor Tablet